From the Journals

Maternal Tdap Vaccine May Lower Infant Pertussis

Study shows maternal Tdap vaccination significantly reduces pertussis incidence in infants younger than 2 months, supporting its use during pregnancy.

Share

5 Key Takeaways

  • 1

    Maternal Tdap vaccination reduced pertussis incidence in US infants under 2 months.

  • 2

    No significant change in pertussis incidence in infants aged 6 to 12 months post-maternal Tdap vaccination.

  • 3

    Study published in JAMA Pediatrics emphasized the importance of increasing Tdap vaccination uptake among pregnant women.

  • 4

    Sensitivity analyses were conducted to ensure data robustness.

  • 5

    Limitations include lack of maternal vaccination status at the individual level and incomplete vaccination history data in the surveillance system.

Original Source(s)

Maternal Tdap Vaccine May Lower Infant Pertussis

Study shows maternal Tdap vaccination significantly reduces pertussis incidence in infants younger than 2 months, supporting its use during pregnancy.

  • by Conexiant News Staff

  • June 24, 2024

  • 3 min

Related Content

What Parents Want in Emergencies

Satisfaction scores rose when parents felt involved in their child's care decisions.

New Data Challenges Pediatric Sinusitis Treatment Guidelines

A JAMA review revealed that only 26% of pediatric ABRS patients treated with placebo required subsequent antibiotic therapy, prompting questions about current guidelines recommending first-line antibiotic use in children with sinusitis.

Are Antibiotics Needed for Pediatric Pneumonia?